Early work by Miledi demonstrated the feasibility of injecting acetylcholine receptors (AChRs)[@cit0001] and proteoliposomes containing AChRs[@cit0002] into *Xenopus* oocytes where they were efficiently incorporated into the oocyte plasma membrane. Additional studies with reconstituted paddle chimera Kv channels[@cit0003] and a novel insect aquaporin channel[@cit0004] established the feasibility of trafficking injected reconstituted protein channels to the oocyte plasma membrane for functional study.

More recently, this method of integral membrane protein injection and incorporation into *Xenopus* oocytes has been elegantly refined to include membrane channel protein synthesized in a wheat-germ cell-free translation system.[@cit0005] In this study, macroscopic oocyte currents derived from injected *Shaker* K protein were characterized pharmacologically and compared with whole oocyte currents derived from *Shaker* K mRNA.[@cit0005] Although this work[@cit0003] established the feasibility of direct injection of integral membrane proteins into Xenopus oocytes, only whole-cell macroscopic currents were reported. In the present study, we compare the properties of channel currents from oocytes injected with cell-free translated Kir1.1 protein with channel currents derived from oocytes injected with Kir1.1 mRNA.

Inward rectifier channel protein for injection into oocytes was prepared using a cell-free translation system.[@cit0006] We chose a single *Cys* variant of Kir1.1b (C189-Kir1.1b) in which 5 normally occurring cysteines had been removed, leaving a single accessible cysteine in the C-terminal domain at 189. This mutant has the same physiological properties as wild-type, but can be readily labeled at the single *Cys* locus for FRET and LRET experiments. The C189-Kir1.1b open reading frame was subcloned into a pEU plasmid used for in vitro transcription of RNA that directs cell-free protein translation in a wheat-germ dialysis reaction (WEPRO2240, CFS, Japan), supplemented with POPE, POPG extruded liposomes to increase yield.[@cit0005] During the 23hr cell-free translation reaction, C189-Kir1.1b channel protein was incorporated into liposomes and recovered from the pellet fraction by centrifugation (18,000g for 3 min at ambient temperature). The single band at 40kDa in the pellet lane of the SDS gel (labeled Kir) is close to the predicted size of a single Kir1.1b subunit ([**Fig. 1**](#f0001){ref-type="fig"}). A western blot confirmed that this band reacted with anti-Kir1.1 antibody. Figure 1.SDS gel of C189-Kir1.1b cell-free reaction products. Proteins were synthesized in a cell-free dialysis reaction with purified RNA (0.7mg/ml) using WEPRO2240 at ambient temperature for 23 hrs. Fractionation of supernatant (S) and pellet (P) were obtained by centrifugation at 18,000g for 3 min at ambient temperature. SDS-PAGE samples were prepared without prior heating. A single C189-Kir1.1b subunit appears as a 40kDa band in both pellet and supernatant lanes.

The C189-Kir1.1b proteoliposome suspension for oocyte injection was obtained by centrifuging and washing the cell-free pellet twice in buffer (vol = 0.6 × translation vol) containing 25mM HEPES-NaOH, 100mM KCl at pH 7.5 and resuspending in 1/20 volume of the original translation buffer. Prior to injection into stage IV Xenopus oocytes, the proteoliposome suspension was treated with 0.01mg/ml RNase A to eliminate any residual RNA, followed by a second wash to eliminate the added RNase.

Twenty-four hours after injection of C189-Kir1.1b proteoliposomes into oocytes, patch-clamp recordings revealed K channels with an average inward conductance (gK) of 36±3pS (n=4), an average open probability (Po) of 0.8±0.1 (n=4), an average open time of 14±2ms (n=4), and an average closed time of 4±3ms (n=4). An example is shown in [**Figure 2**](#f0002){ref-type="fig"}. In contrast to previous studies with *Shaker* cell-free protein injection, where peak expression occurred after 12 hrs,[@cit0005] optimal C189-Kir1.1 channel density at the oocyte plasma membrane required 24 hrs incubation at 18°C. We do not understand the reason for this different time course, although it may be related to differences between Kir and Kv. Figure 2.Inward rectifier channel currents recorded from a cell-attached patch on an oocyte, 24hrs after injection with C189-Kir1.1b cell-free synthesized protein incorporated into POPG (25%), POPE (75%) liposomes. Patch pipette: 50mM KCl, 1mM CaCl~2~ at pH 6.5. Bath solution: 5mM KCl, 45mM NaAcetate, 0 Ca at pH 8. Oocyte Vm = −75mV. HP(mV)=pipette minus bath. Inward single channel conductance = 32pS. Records filtered at 900Hz; closed current level denoted by c.

We also confirmed that oocytes injected with C189-Kir1.1b proteoliposomes exhibited pH gated channels ([**Fig 3**](#f0003){ref-type="fig"}) similar to what has been extensively reported for oocytes injected with Kir1.1b mRNA.[@cit0007] In excised patches, a decrease in cytoplasmic-side pH from 7.4 to 6.0 blocked inward C189-Kir1.1b currents within a few secs ([**Fig. 3**](#f0003){ref-type="fig"}). Figure 3.pH gating of C189-Kir1.1b inward rectifier channel currents, recorded from an inside-out excised oocyte patch, 24hrs after injection of cell-free C189-Kir1.1b proteoliposomes (25% POPG, 75% POPE) into an oocyte. Patch pipette: 50mM KCl,1mM CaCl~2~ at pH 6.5. Bath solution: 5mM KCl, 45mM NaCl, 0Ca changed from pH 7.4 to pH 6, causing channel shutdown. Records filtered at 900Hz; closed current level denoted by c.

The above results with cell-free protein injection were compared to patch-clamp currents obtained from *Xenopus* oocytes injected with C189-Kir1.1b mRNA. Oocytes expressing C189-Kir1.1b displayed channel currents with an average inward gK of 34±3pS (n=12), an average open probability (Po) of 0.7±0.1 (n=4), an average open time of 12.5±3ms (n=4), and an average closed time of 6±2ms (n=4). An example is illustrated in [**Figure 4**](#f0004){ref-type="fig"}. These channel currents were almost identical to currents arising from direct injection of C189-Kir1.1b proteoliposomes into oocytes ([**Fig. 2**](#f0002){ref-type="fig"}). In addition, whole oocyte currents, derived from proteliposome injection, were also indistinguishable from whole oocyte currents derived from mRNA injection (not shown), further substantiating equivalence of the 2 techniques. Figure 4.Inward rectifier channel currents recorded from a cell-attached patch on an oocyte, 24hrs after injection with C189-Kir1.1b mRNA. Patch pipette: 50mM KCl,1mM CaCl~2~ at pH 6.5. Bath solution: 5mM KCl, 45mM NaAcetate, 0 Ca at pH 8. Oocyte Vm = −75mV. HP(mV) = pipette minus bath. Inward single channel conductance = 30pS. Records filtered at 900Hz; closed current level denoted by c.

In summary, the present study confirms that injection of either cell-free protein or mRNA (derived from the same C189-Kir1.1b DNA template) produce nearly equivalent single-channel currents in *Xenopus* oocytes. This also demonstrates (as proof of principle) that proteoliposome injection into *Xenopus* oocytes can be used to conveniently screen integral membrane proteins derived from in vitro, cell-free translation.

Despite the fact that our C189-Kir1.1b protein was not glycosylated during cell-free translation, it was nonetheless trafficked to the plasma membrane after cytoplasmic injection where it consistently appeared in an outside-out orientation. Even when patch pipette pH was raised above 7 (allowing inside-out channel activation), channels were never detected in a reverse (inside-out) orientation. This suggests that the oocyte may recognize the orientation of exogenous channel proteins and insert them correctly into the membrane. However, we cannot exclude the possibility that some cell-free C189-Kir1.1b channels were incorporated in a reverse (inside-out) orientation, but remained silent since the PIP2 required at the internal side of Kir1.1 for activation is absent from the outer leaflet of the oocyte plasma membrane.
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